Laccase activity in Cryptococcus gattii strains isolated from goats

Revista Iberoamericana de Micologia

Volumn 25, Issue 3, 2008, Pages 150-153

  Alvarado Ramírez, Eidi ^a   Torres Rodríguez, Josep M ^a   Sellart, Maite ^a   Vidotto, Valerio ^b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

Cryptococcus gattii; Cryptococcus neoformans; Laccase; Pathogenic factor; Serotypes

Indexed keywords

LACCASE; LEVODOPA;

ANIMAL CELL; ARTICLE; AUTOPSY; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS; CRYPTOCOCCUS GATTII; CRYPTOCOCCUS NEOFORMANS; ENZYME ACTIVITY; EPIDEMIC; FUNGAL STRAIN; FUNGAL VIRULENCE; FUNGUS ISOLATION; GOAT; HUMAN; NONHUMAN; SEROTYPE; SPAIN; STRAIN DIFFERENCE; STRAIN IDENTIFICATION;

ANIMALIA; CAPRA HIRCUS; CRYPTOCOCCUS GATTII; FILOBASIDIELLA NEOFORMANS;

EID: 53849137719     PISSN: 11301406     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1130-1406(08)70035-4     Document Type: Article

References (26)

1. Baró T, Torres-Rodríguez JM, Hermoso de Mendoza M, Morera Y, Alía C. First Identification of Autochthonous Cryptococcus neoformans var. gattii Isolated from goats with predominantly severe pulmonary disease in Spain. J Clin Microbiol 1998; 36: 458-461.
2. Casadevall A, Perfect RJ. Cryptococcus neoformans. Washington DC, ASM Press, 1998.
3. Colom MF, Frasés S, Ferrer C, Jover A, Andreu M, Reus S, Sánchez M, Torres-Rodríguez JM. First case of human cryptococcosis due to Cryptococcus neoformans var. gattii in Spain. J Clin Microbiol 2005; 43: 4538-4550.
4. Doering TL, Nosanchuk JD, Roberts WK, Casadevall A. Melanin as a potential cryptococcal defence against microbicidal proteins. Med Mycol 1999; 37: 175-181.
5. Duncan C, Stephen C, Lester S, Bartlett KH. Follow-up study of dogs and cats with asymptomatic Cryptococcus gattii infection. Med Mycol 2005; 43: 663-666.
6. Ikeda R, Sugita T, Jacobson ES, Shinoda T. Laccase and melanization in clinically important Cryptococcus species other than Cryptococcus neoformans. J Clin Microbiol 2002; 40: 1214-1218.
7. Kwon-Chung KJ, Boekhout T, Fell JW, Diaz M. Proposal to conserve the name Cryptococcus gattii against C. hondurianus and C. bacillisporus (Basidiomycota, Hymenomycetes, Tremenomycetidae). Taxon 2002; 51: 804-806.
8. Kwon-Chung KJ, Polacheck I, Popkin TJ Melanin-lacking mutants of Cryptococcus neoformans and their virulence for mice. J Bacteriol 1982; 150: 1414-1421.
9. Kwon-Chung KJ, Rhodes JC. Encapsulation and melanin production as indicators of virulence in Cryptococcus neoformans. Infect Immun 1986; 51: 218-223.
10. Liu L, Tewari RP, Williamson PR. Laccase protects Cryptococcus neoformans from antifungal activity of alveolar macrophages. Infect Immun 1999; 67: 6034-6039.
11. Mitchell DH, Sorrell TC, Allworth AM, Heath CH, McGregor AR, Papanaoum K, Richards MJ, Gottlieb T. Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome. Clin Infect Dis 1995; 20: 611-616.
12. Mitchell TG, Perfect JR. Cryptococcosis in the era of AIDS -100 years after the discovery of Cryptococcus neoformans. Clin Med Rev 1995; 8: 515-548.
13. Nuñez M, Peakock JE, Chin R Jr. Pulmonary cryptococcosis in the immunocompetent host. Therapy with oral fluconazole: a report of four cases and review of the literature. Chest 2000; 118: 527-534.
14. Nurudeen TA, Ahearn DG. Regulation of melanin production by Cryptococcus neoformans. J Clin Microbiol 1979; 10: 724-729.
15. Parks LC. Handbook of Microbiological Media. Boca Ratón, CRC press, 1993.
16. Prabhakaran K, Harris EB, Kirchheimer WF. Effect of inhibitors on phenoloxidase of Mycobacterium leprae. J Bacteriol 1969; 100: 935-938.
17. Raso TF, Werther F, Miranda ET, Mendes-Giannini MJ. Cryptococcosis outbreak in psittacine birds in Brazil. Med Mycol 2004; 42: 355-362.
18. Speed B, Dunt D. Clinical and host differences between infections with the two varieties of Cryptococcus neoformans. Clin Infect Dis 1995; 21: 28-36.
19. Torres-Rodríguez JM, Hermoso de Mendoza M, Alvarado-Ramírez E, Segura-Roca G. Cryptococcosis by Cryptococcus gattii in immunocompetent goats in Spain and review of the literature. Acta Sci Vet 2006; 34: 245-253.
20. Torres-Rodríguez JM, Morera Y, Corominas JM, Castañeda E. Pathogenicity of Cryptococcus neoformans var. gattii in an immunocompetent mouse model. Med Mycol 2003; 41: 59-63.
21. Van Duin D, Casadevall A, Nosanchuk JD. Melanization of Cryptococcus neoformans and Histoplasma capsulatum reduces their susceptibilities to amphotericin B and caspofungin. Antimicrob Agents Chemother 2002; 46: 3394-3400.
22. Vidotto V, Defina N, Pugliese A, Aoki S, Nakamura K, Takeo K. Effect of different K+ concentrations on Cryptococcus neoformans phenoloxidase activity. Mycopathologia 2002; 156: 171-176.
23. Walton FJ, Idnum A, Heitman. Novel gene functions required for melanization of the human pathogen Cryptococcus neoformans. Mol Microbiol 2005; 57: 1381-1396.
24. Waters L, Nelson M. Cryptococcal disease and HIV infection. Expert Opin Pharmather 2005; 6: 2633-2644.
25. Williamson PR. Biochemical and molecular characterization of the diphenol oxidase of Cryptococcus neoformans: identification as a laccase. J Bacteriol 1994; 176: 656-664.
26. Zhu X, Gibbons J, Garcia-Rivera J, Casadevall A, Williamson PR. Laccase of Cryptococcus neoformans is a cell wall-associated virulence factor. Infect Immun 2001; 69: 5589-5596.